Stromal KITL/SCF promotes pancreas tissue homeostasis and restrains tumor progression
Onate, M. K.; Oon, C.; Bhattacharyya, S.; Low, V.; Chen, C.; Zhao, X.; Yan, Z.; Hang, Y.; Kim, S. K.; Xia, Z.; Sherman, M. H.
Show abstract
Components of normal tissue architecture serve as barriers to tumor progression. Inflammatory and wound-healing programs are requisite features of solid tumorigenesis, wherein alterations to immune and non-immune stromal elements enable loss of homeostasis during tumor evolution. The precise mechanisms by which normal stromal cell states limit tissue plasticity and tumorigenesis, and which are lost during tumor progression, remain largely unknown. Here we show that healthy pancreatic mesenchyme expresses the paracrine signaling molecule KITL, also known as stem cell factor, and identify loss of stromal KITL during tumorigenesis as tumor-promoting. Genetic inhibition of mesenchymal KITL in the contexts of homeostasis, injury, and cancer together indicate a role for KITL signaling in maintenance of pancreas tissue architecture, such that loss of the stromal KITL pool increased tumor growth and reduced survival of tumor-bearing mice. Together, these findings implicate loss of mesenchymal KITL as a mechanism for establishing a tumor-permissive microenvironment. Statement of significanceBy analyzing transcriptional programs in healthy and tumor-associated pancreatic mesenchyme, we find that a sub-population of mesenchymal cells in healthy pancreas tissue express the paracrine signaling factor KITL. Loss of mesenchymal KITL is an accompanying and permissive feature of pancreas tumor evolution, with potential implications for cancer interception.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mesenchymal Lineage Heterogeneity Underlies Non-Redundant Functions of Pancreatic Cancer-Associated Fibroblasts 97%
- Netrin G1 promotes pancreatic tumorigenesis through cancer associated fibroblastdriven nutritional support and immunosuppression 97%
- ROR2 regulates cellular plasticity in pancreatic neoplasia and adenocarcinoma 96%
Similar papers in this journal
- Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1 95%
- A Targeted Combination Therapy Achieves Effective Pancreatic Cancer Regression And Prevents Tumor Resistance 94%
- Ki-67 promotes sequential stages of tumourigenesis by enabling cellular plasticity 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.